Can we reduce the burden of musculoskeletal conditions? The European action towards better musculoskeletal health

References 

1. Anon . The bone and joint decade 2000–2010 for prevention and treatment of musculoskeletal disorders. Lund, Sweden, April 17–18, 1998. Proceedings. Acta Orthopaedica Scandinavica. Supplementum. 1998;281:1–86
   • MEDLINE
2. Woolf AD, Akesson K. Understanding the burden of musculoskeletal conditions. The burden is huge and not reflected in national health priorities. British Medical Journal. 2001;322:1079–1080
3. European Opinion Research Group EEIG . Health, Food and Alcohol and Safety. Special Eurobarometer 186. European Commission; 2003;Available at: http://ec.europa.eu/health/ph_determinants/life_style/alcohol/documents/ebs_186_en.pdf
4. Picavet HS, Hazes JM. Prevalence of self reported musculoskeletal diseases is high. Annals of the Rheumatic Diseases. 2003;62(7):644–650
   • MEDLINE
   • CrossRef
5. Woolf AD, Zeidler H, Haglund U, et al. Musculoskeletal pain in Europe: its impact and a comparison of population and medical perceptions of treatment in eight European countries. Annals of the Rheumatic Diseases. 2004;63(4):342–347
   • MEDLINE
   • CrossRef
6. Murray CJL, Lopez AD. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries and Risk Factors in 1990 and Projected to 2020. 1st edn.. Cambridge: Harvard University Press; 1996;
7. EU Directorate-General for Employment, Industrial Relations and Social Affairs . Report on Osteoporosis in the European Community: Action for Prevention. Luxembourg: European Communities; 1998;Available at: http://www.osteofound.org/publications/pdf/eu_report_98.pdf
8. Badley EM, Tennant A. Impact of disablement due to rheumatic disorders in a British population: estimates of severity and prevalence from the Calderdale Rheumatic Disablement Survey. Annals of the Rheumatic Diseases. 1993;52(1):6–13
   • MEDLINE
   • CrossRef
9. Jacobson L, Lindgren B. Vad kostar sjukdomarna? (What are the costs of illness?), Stockholm: Socialstyrelsen [National Board of Health and Welfare]; 1996;
10. Rasker JJ. Rheumatology in general practice. British Journal of Rheumatology. 1995;34(6):494–497
    • MEDLINE
11. National Board on Health and Welfare (Sweden) . Yearbook of Health and Medical Care, 2001. Stockholm: National Board on Health and Welfare; 2001;
12. Lidgren L. The bone and joint decade 2000–2010: an update. Acta Orthopaedica Scandinavica. 2000;71(1):3–6
    • MEDLINE
13. Delmas PD, Anderson M. Launch of the bone and joint decade 2000–2010. Osteoporosis International. 2000;11(2):95–97
14. Hazes JM, Woolf AD. The bone and joint decade 2000–2010. The Journal of Rheumatology. 2000;27(1):1–3
    • MEDLINE
15. Weinstein SL. 2000–2010: The bone and joint decade. The Journal of Bone and Joint Surgery. American Volume. 2000;82(1):1–3
    • MEDLINE
16. Woolf AD. The bone and joint decade 2000–2010. Annals of the Rheumatic Diseases. 2000;59(2):81–82
    • MEDLINE
    • CrossRef
17. European Action Towards Better Musculoskeletal Health: A Public Health Strategy to Reduce the Burden of Musculoskeletal Conditions. A Bone and Joint Decade Report, 2004. The European Bone and Joint Health Strategies Project. The Bone and Joint, Decade, Lund, Sweden. Available at: http://ec.europa.eu/health/ph_projects/2000/promotion/fp_promotion_2000_frep_15_en.pdf.
18. WHO . The International Classification of Functioning, Disability and Health (ICF). Geneva: World Health Organization; 2001;
19. World Health Organisation/Europe . Health 21: “The Health for All” Policy Framework for the WHO European Region - 21 Targets for the 21st Century. European Health for All Series. Geneva: WHO Regional Office for Europe; 1999;